» Articles » PMID: 37250456

Emerging Functions and Clinical Applications of Exosomal MicroRNAs in Diseases

Overview
Date 2023 May 30
PMID 37250456
Authors
Affiliations
Soon will be listed here.
Abstract

Exosomes are an important group of extracellular vesicles that transfer several kinds of biomolecules and facilitate cell-cell communication. The content of exosomes, particularly the amounts of microRNA (miRNAs) inside these vesicles, demonstrates a disease-specific pattern reflecting pathogenic processes and may be employed as a diagnostic and prognostic marker. miRNAs may enter recipient cells through exosomes and generate a RISC complex that can cause degradation of the target mRNAs or block translation of their corresponding proteins. Therefore, exosome-derived miRNAs constitute an important mechanism of gene regulation in recipient cells. The miRNA content of exosomes can be used as an important tool in the detection of diverse disorders, particularly cancers. This research field has an important situation in cancer diagnosis. In addition, exosomal microRNAs offer a great deal of promise in the treatment of human disorders. However, there are still certain challenges to be resolved. The most important challenges are as follow: the detection of exosomal miRNAs should be standardized, exosomal miRNAs-associated studies should be conducted in large number of clinical samples, and experiment settings and detection criteria should be consistent across different labs. The goal of this article is to present an overview of the effects of exosome-derived microRNAs on a variety of diseases, including gastrointestinal, pulmonary, neurological, and cardiovascular diseases, with a particular emphasis on malignancies.

Citing Articles

Unlocking the Secrets of Extracellular Vesicles: Orchestrating Tumor Microenvironment Dynamics in Metastasis, Drug Resistance, and Immune Evasion.

Mir R, Baba S, Elfaki I, Algehainy N, Alanazi M, Altemani F J Cancer. 2024; 15(19):6383-6415.

PMID: 39513123 PMC: 11540496. DOI: 10.7150/jca.98426.


Exosomal long non-coding RNAs in cancer: Interplay, modulation, and therapeutic avenues.

Marima R, Basera A, Miya T, Damane B, Kandhavelu J, Mirza S Noncoding RNA Res. 2024; 9(3):887-900.

PMID: 38616862 PMC: 11015109. DOI: 10.1016/j.ncrna.2024.03.014.


Understanding the multifaceted role of miRNAs in Alzheimer's disease pathology.

Kaur S, Verma H, Kaur S, Gangwar P, Yadav A, Yadav B Metab Brain Dis. 2023; 39(1):217-237.

PMID: 37505443 DOI: 10.1007/s11011-023-01265-9.

References
1.
Yan W, Wang Y, Chen Y, Guo Y, Li Q, Wei X . Exosomal miR-130b-3p Promotes Progression and Tubular Formation Through Targeting PTEN in Oral Squamous Cell Carcinoma. Front Cell Dev Biol. 2021; 9:616306. PMC: 8019696. DOI: 10.3389/fcell.2021.616306. View

2.
Du Q, Ye X, Lu S, Li H, Liu H, Zhai Q . Exosomal miR-30a and miR-222 derived from colon cancer mesenchymal stem cells promote the tumorigenicity of colon cancer through targeting MIA3. J Gastrointest Oncol. 2021; 12(1):52-68. PMC: 7944155. DOI: 10.21037/jgo-20-513. View

3.
Xue P, Huang S, Han X, Zhang C, Yang L, Xiao W . Exosomal miR-101-3p and miR-423-5p inhibit medulloblastoma tumorigenesis through targeting FOXP4 and EZH2. Cell Death Differ. 2021; 29(1):82-95. PMC: 8738741. DOI: 10.1038/s41418-021-00838-4. View

4.
Ma Y, Zhou Y, Xiao Q, Zou S, Zhu Y, Ping P . Seminal exosomal miR-210-3p as a potential marker of Sertoli cell damage in Varicocele. Andrology. 2020; 9(1):451-459. DOI: 10.1111/andr.12913. View

5.
Wang D, Wang X, Song Y, Si M, Sun Y, Liu X . Exosomal miR-146a-5p and miR-155-5p promote CXCL12/CXCR7-induced metastasis of colorectal cancer by crosstalk with cancer-associated fibroblasts. Cell Death Dis. 2022; 13(4):380. PMC: 9021302. DOI: 10.1038/s41419-022-04825-6. View